Skip to main content
. 2018 Oct 9;5(4):83. doi: 10.3390/bioengineering5040083

Figure 8.

Figure 8

Cell viability trend of U87-MG treated with 15 µM GSK, that corresponds to the release profile. * (p < 0.05).